Skip to main content
Published locations for FDA grants accelerated approval to ipilimumab/nivolumab combo for CRC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA grants accelerated approval to ipilimumab/nivolumab combo for CRC
User login
Username
Password
Reset your password
/content/fda-grants-accelerated-approval-ipilimumab/nivolumab-combo-crc
/oncologypractice/article/170208/immuno-oncology/fda-grants-accelerated-approval-ipilimumab/nivolumab
/hematology-oncology/article/170208/immuno-oncology/fda-grants-accelerated-approval-ipilimumab